MedTrace Logo

Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

NCT00675740 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2010-02-02

No results posted yet for this study

Summary

The aim of this study is to prospectively assess the relative benefits of either treatment with rosiglitazone or physical exercise on endothelial function in patients with impaired fasting glucose or impaired glucose tolerance and coronary artery disease (CAD).

Conditions

  • Impaired Glucose Tolerance

Interventions

DRUG

rosiglitazone

tablets 4 mg daily

BEHAVIORAL

physical exercise

stationary bike 5-6 times a week

OTHER

control

control without intervention

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2007-02-28
Completion
2007-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00675740 on ClinicalTrials.gov